YONDELIS® receives marketing approval in Japan for the treatment of STS

(Pharmamar) PharmaMar announced that its partner in Japan, Taiho Pharmaceutical, received marketing approval for YONDELIS® (trabectedin) by the Japanese Minister of Health, Labour and Welfare for the treatment of patients with soft tissue sarcoma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news